Jul 24, 2018 Yale selected as one of 25 clinical trial sites for treatment of neurological diseases Yale selected as one of 25 clinical trial sites for treatment of neurological diseasesNeuroNEXT, funded by the National Institutes of Health's (NIH) National Institute of Neurological Disorders and Stroke (NINDS), is the premier NIH ... read morePublished on 2018-07-24